2009
October 11, 2017
|By natasa
- Exedral® (Exemestane), another anticancer pharmaceutical product developed internally, successfully passed clinical testing and registration begun in the EU and other countries.
- Remedica received the Export Award for Industry and under the company’s Corporate Social Responsibility policy, the “Remedica Volunteer” team was formed.
- A new cardiovascular product, Acapril® (Ramipril) was registered.
